查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067384

罕見疾病診斷人工智慧市場：按組件、部署模式、技術、應用、最終用戶、國家和地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

AI in Rare Disease Diagnostics Market, By Component, By Deployment Mode, By Technology, By Application, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年，用於罕見疾病診斷的人工智慧市場規模預計為 17.089 億美元，預計從 2026 年到 2033 年將以 29.0% 的複合年成長率成長。

人工智慧在罕見疾病診斷的應用是指利用機器學習和模式識別技術分析複雜的臨床數據、基因組數據和影像數據的系統。這有望加速識別先前可能被忽略的疾病生物標記。由於全球新生兒篩檢的普及、個人化醫療治療方案的增加以及開發中國家對人工智慧和機器學習技術的應用，人工智慧在罕見疾病診斷市場的應用預計將會成長。 2025年7月，PathAI推出了一款名為「精準病理網路（PPN）」的新產品，這是一個基於人工智慧的平台，旨在擴大人工智慧病理診斷產品的覆蓋範圍，並加速精準醫療的發展。該平台將有助於加速個人化治療。因此，預計會有更多醫療機構採用人工智慧診斷和精準醫療技術，加速人工智慧在罕見疾病診斷市場的成長。

人工智慧在罕見疾病診斷市場的應用—市場動態

對罕見疾病早期準確診斷的需求日益成長，推動了市場需求。

對罕見疾病早期及時檢測的需求日益成長，加上早期檢測不足可能導致誤診，這些因素正推動新技術的廣泛應用。基因測序和人工智慧資料處理等技術創新能夠幫助醫生快速且準確地診斷罕見疾病。早期檢測使患者能夠及時獲得適當的干預和有效的治療。

醫療產業對基於人工智慧的診斷工具的需求日益成長，這些工具能夠實現罕見疾病的早期精準診斷。這將有助於更快、更準確地診斷那些難以診斷的疾病，尤其是那些由多種遺傳因素引起的疾病。例如，根據世界經濟論壇預測，到2026年，全球將有超過3億人患有罕見疾病，涵蓋約7,000種不同的疾病。儘管基因組學和精準醫療取得了進展，但由於醫療數據分散以及公眾對疾病認知不足，許多患者仍然面臨著漫長的診斷過程和醫療資源匱乏的問題。此外，儘管基因組學和個人化醫療取得了進展，但由於缺乏整合的資訊以及公眾對疾病認知不足，患者仍然面臨診斷延遲甚至漏診的困境。因此，鑑於全球罕見疾病病例數量的不斷成長，人工智慧驅動的診斷技術正被廣泛應用。

人工智慧在罕見疾病診斷領域的市場—市場區隔分析：

全球罕見疾病診斷人工智慧市場按組件、部署模式、技術、應用、最終用戶和地區進行細分。

在技​​術領域，機器學習在人工智慧（AI）市場中佔據了顯著的市場佔有率，尤其是在罕見疾病診斷領域。這主要得益於醫療服務機構和研究人員對機器學習的日益重視，使他們能夠分析大量的臨床和基因數據，從而加速診斷。例如，根據經合組織（OECD）2025年5月發布的報告，機器學習在德國的應用正在迅速擴展。一項針對德國企業的全國性調查顯示，13.3%的企業已經在使用人工智慧技術，另有9.2%的企業計劃在未來實施。此外，另一項調查顯示，23%的企業計劃利用人工智慧。因此，隨著醫療保健行業企業採用率的提高，機器學習在罕見疾病診斷領域的應用預計將更加普及。

在“應用領域”，遺傳性疾病在人工智慧罕見疾病診斷市場中佔據了相當大的佔有率。這是因為人工智慧在基因組分析和罕見疾病診斷的應用正日益增加。例如，根據英國遺傳聯盟組織（Genetic Alliance Org 英國）統計，80%的罕見疾病是遺傳性的，而英國每年有超過6000名兒童出生時患有罕見遺傳疾病，這些疾病要么未被診斷，甚至沒有被命名。此外，四分之一的罕見疾病患者至少需要等待三年才能獲得確診，這凸顯了遺傳患者病率上升和複雜性增加所帶來的嚴峻醫療挑戰。因此，隨著罕見疾病病例數的增加，醫療系統越來越依賴人工智慧工具來更快、更方便診斷患者。

人工智慧在罕見疾病診斷領域的市場—區域分析

目前，北美在罕見疾病診斷人工智慧市場佔據顯著佔有率，這主要得益於罕見疾病發病率的上升、基因組研究的拓展以及相關法規的支持。例如，根據美國食品藥物管理局（FDA）的數據，截至2026年2月，將有超過1萬種罕見疾病影響超過3,000萬美國人，相當於每十個美國人中就有一人患病。此外，約50%的罕見疾病患者是兒童，凸顯了日益沉重的醫療負擔，以及對先進診斷技術和標靶治療方案日益成長的需求。因此，人工智慧在北美被擴大用於診斷日益增多的罕見疾病病例。

在亞太地區，由於醫療領域的進步、人們對罕見疾病的認知不斷提高以及人工智慧解決方案在診斷領域的應用日益廣泛，用於罕見疾病診斷的人工智慧市場正在快速成長。例如，根據印度新聞資訊局（PIB）報道，到2026年，在總理阿尤斯曼·巴拉特健康基礎設施計畫（PM-ABHIM）的支持下，印度將大幅加強其醫療基礎設施建設。這包括建造9519個健康健康中心、5456個都市區健康健康中心、2151個公共衛生設施、744個綜合公共衛生實驗室和622個重症監護醫院設施。因此，亞太地區利用人工智慧快速診斷罕見疾病的案例將會增加。

日本罕見疾病診斷領域人工智慧市場—國別分析

日本目前正大力資助和支持醫療領域的技術研發，這為從事創新的企業創造了巨大的機會。例如，根據英聯邦基金會預測，到2026年，日本政府仍將是醫療保健領域的主要出資方，公共資金將佔醫療保健總支出的87%。此外，儘管65歲及以上人口僅佔總人口的29%，但他們卻佔醫療保健總支出的62%。這凸顯了日本政府致力於在老齡化社會中支持醫療保健服務，並維持全國範圍內的全民醫療保健的堅定決心。因此，日本龐大的老齡人口和健全的公共醫療保健體系將繼續為醫療創新創造新的機會。

目錄

第1章：罕見疾病診斷領域人工智慧市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：人工智慧在罕見疾病診斷領域的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：人工智慧在罕見疾病診斷的產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：人工智慧在罕見疾病診斷領域的市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：人工智慧在罕見疾病診斷領域的市場

  • 2025年罕見疾病診斷領域人工智慧市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：罕見疾病診斷領域的人工智慧市場：按組件分類

  • 概述
    • 基於細分市場的市場佔有率分析：按組件
    • 軟體
    • 硬體
    • 服務

第8章：罕見疾病診斷領域的人工智慧市場：按部署模式分類

  • 概述
    • 基於細分市場的市場佔有率分析：按部署模式
    • 基於雲端的
    • 現場

第9章：罕見疾病診斷領域的人工智慧市場：按技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 機器學習
    • 深度學習
    • 自然語言處理
    • 電腦視覺
    • 其他

第10章：罕見疾病診斷領域的人工智慧市場：按應用分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 遺傳性疾病
    • 代謝性疾病
    • 神經病變
    • 腫瘤疾病
    • 其他

第11章：罕見疾病診斷領域的人工智慧市場：按最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 醫院
    • 研究機構
    • 診斷中心
    • 其他

第12章：罕見疾病診斷領域的人工智慧市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第13章：主要供應商分析：人工智慧在罕見疾病診斷領域的應用

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Bayer
    • Deep Genomics
    • Congenica
    • Enlitic
    • Face2Gene
    • BioMind
    • Fabric Genomics
    • FDNA
    • IBM Watson Health
    • Invitae
    • Freenome
    • GeneDx
    • Mendel.ai
    • Nostos Genomics
    • PathAI
    • SOPHiA GENETICS
    • Tempus Labs
    • PhenoTips
    • Raremark
    • Others

第14章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6725

AI in Rare Disease Diagnostics market size was valued at US$ 1,708.9 Million in 2025, expanding at a CAGR of 29.0% from 2026 to 2033.

Artificial intelligence in rare disease diagnosis refers to a system that makes use of machine learning and pattern recognition to analyze complex clinical, genomic, and imaging data, where it can be used to potentially expedite recognition of disease biomarkers that would otherwise be missed. Artificial intelligence applications in the rare disease diagnostic market will experience growth due to the rising prevalence of newborn screenings across the globe, personalized medicine treatment options, and adoption of artificial intelligence and machine learning technologies in developing countries. In July 2025, PathAI launched its new product known as Precision Pathology Network (PPN). It is an AI-based platform aimed at extending the reach of pathology products based on artificial intelligence to promote initiatives on precision medicine. It assists in facilitating the personalization of treatment. As a result, more healthcare providers are using AI-powered diagnostics and precision medicine, which is expected to speed up the growth of AI in the rare disease diagnostics market.

AI in Rare Disease Diagnostics Market- Market Dynamics

Growing Need for Early and Accurate Rare Disease Diagnosis Driving Market Demand

Rising requirement for early & timely detection of rare diseases leads to rise in usage of new technology due to failure to detect earlier lead to wrong diagnosis of disease. Technological innovations such as genomic sequencing, and data processing via AI, help the physician diagnose rare diseases quickly & accurately. Early detection ensures proper intervention and effective treatment is given to patients.

There is increasing demand from the healthcare industry for AI-based diagnostic tools for early and accurate diagnosis of rare diseases, which would ensure that diagnosis of difficult diseases, mostly due to multiple genetic factors, happens quicker and with greater accuracy. For instance, in 2026, according to the World Economic Forum, more than 300 million people globally live with rare diseases, while the conditions encompass approximately 7,000 distinct disorders. Despite advances in genomics and precision medicine, many patients still face lengthy diagnostic delays and remain underserved due to fragmented healthcare data and limited disease awareness. However, despite the advancements in genomics and personalized medicine, patients still suffer from delayed diagnosis and under diagnosis because of lack of integration and insufficient disease awareness. Thus, in view of rising cases of rare diseases around the world, AI-powered diagnostics are gaining widespread adoption.

AI in Rare Disease Diagnostics Market- Segmentation Analysis:

The Global AI in Rare Disease Diagnostics market is segmented on the basis of Component, Deployment Mode, Technology, Application, End User, and Region.

Machine learning under the technology segment holds a notable share in the AI in Rare Disease Diagnostics market because of the rising use by healthcare services, as well as by researchers, to analyze large volumes of data pertaining to clinical and genetic aspects for faster diagnosis. For instance, in May 2025, according to the OECD.org, adoption of machine learning has been growing rapidly in Germany, and based on the national survey carried out among companies in the country, 13.3% already use the technology of artificial intelligence, while 9.2% have plans to apply it in the future. In addition, another survey suggests that 23% of firms plan to use artificial intelligence. Thus, as the adoption rate increases among companies in healthcare, machine learning diagnostics for rare diseases can be expected to gain popularity.

The genetic disorders in application segment hold a prominent share in the AI in Rare Disease Diagnostics market because the use of artificial intelligence to analyze the genome and diagnose rare diseases has increased over time. For instance, according to Genetic Alliance Org UK, 80% of rare conditions are genetic in origin, and over 6,000 children in the UK are born each year with a genetic condition so rare that it remains undiagnosed or unnamed. Additionally, 1 in 4 patients with a rare condition wait at least three years to receive a confirmed diagnosis, underscoring the increasing healthcare challenges associated with the rising prevalence and complexity of genetic disorders. Hence, because rare disease cases are increasing, healthcare systems are relying on AI tools to diagnose patients faster and more easily.

AI in Rare Disease Diagnostics Market- Geographical Insights

Currently, North America holds a significant share of the AI in Rare Disease Diagnostics market because of the rising incidence rate of rare disease cases, increasing genomics studies, and supportive regulations. For instance, in Feb. 2026, according to the U.S. Food and Drug Administration (FDA) Gov., more than 10,000 rare diseases collectively affect over 30 million Americans, representing approximately 1 in every 10 people in the United States. Additionally, nearly 50% of individuals living with rare diseases are children, highlighting the growing healthcare burden and the increasing need for advanced diagnostic technologies and targeted treatment solutions for rare disease management. Therefore, North America is increasingly using AI to diagnose the growing number of rare disease cases.

The Asia-Pacific region is witnessing rapid growth in the AI in Rare Disease Diagnostics market because of developments in the healthcare sector, increased awareness regarding rare diseases, and growing use of AI solutions in diagnostics. For instance, in 2026, according to the Press Information Bureau (PIB), India is significantly strengthening its healthcare infrastructure through support from the PM-ABHIM (Pradhan Mantri-Ayushman Bharat Health Infrastructure Mission), as per PIB (Press Information Bureau). This includes development of 9,519 health and wellness centers, 5,456 urban health and wellness centers, 2,151 public health unit buildings, 744 integrated public health laboratories, and 622 critical care hospital building blocks. As a result, there will be an increase in rapid diagnosis of rare diseases using AI in the Asia-Pacific region.

Japan AI in Rare Disease Diagnostics Market- Country Insights

Japan is currently funding and supporting the development of technology within the field of health care, presenting great prospects for business operators involved in technological innovation. For instance, in 2026, according to the Commonwealth Fund, Japan's government remains a major healthcare financier, with public funding accounting for 87% of total health spending and older adults aged 65 years and above representing 29% of the population but accounting for 62% of healthcare expenditures. This highlights Japan's substantial government commitment toward supporting healthcare services for its aging population and maintaining universal healthcare access nationwide. Hence, Japan's older population and strong public healthcare system keep opening up new opportunities for healthcare innovation.

AI in Rare Disease Diagnostics Market- Competitive Landscape:

The major characteristic of the AI in the rare disease diagnostics market is the presence of leading firms like Bayer, BioMind, Congenica, Deep Genomics, and Enlitic. They are trying to create AI-based diagnostic tools using innovations and partnerships with others. They keep on investing in the development of analytics and machine learning technologies in this industry. In June 2025, BioMind launched the improved version of their BioMind AI diagnostic platform for analyzing rare neurological and imaging-based diseases. It uses deep learning and automated image analysis for analyzing the diseases. This initiative of BioMind has helped improve their standing in the field of artificial intelligence-assisted diagnostics. Hence, the constant improvement in the field of AI is positively impacting the accuracy of disease diagnosis in the market.

Recent Developments:

In January 2026, Enlitic expanded its Enlitic Curie(TM) Platform with advanced AI-powered medical imaging data standardization and diagnostic workflow capabilities, supporting healthcare providers in managing complex diagnostic datasets. Strengthens Enlitic's role in AI-enabled diagnostic infrastructure and improves data quality for rare disease detection and clinical decision-making.

In September 2025, Congenica was acquired by AI-driven genomic analysis company SeqOne to create a larger clinical genomics software platform focused on genomic interpretation and rare disease diagnostics. The combined organization serves more than 160 laboratories across 30 countries, strengthening capabilities in AI-powered genomic medicine. Enhances Congenica's global reach in rare disease diagnostics and strengthens its AI-based genomic analysis capabilities.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI IN RARE DISEASE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bayer
  • Deep Genomics
  • Congenica
  • Enlitic
  • Face2Gene
  • BioMind
  • Fabric Genomics
  • FDNA
  • IBM Watson Health
  • Invitae
  • Freenome
  • GeneDx
  • Mendel.ai
  • Nostos Genomics
  • PathAI
  • SOPHiA GENETICS
  • Tempus Labs
  • PhenoTips
  • Raremark
  • Others

GLOBAL AI IN RARE DISEASE DIAGNOSTICS MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033

  • Software
  • Hardware
  • Services

GLOBAL AI IN RARE DISEASE DIAGNOSTICS MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2020 - 2033

  • Cloud-Based
  • On-Premises

GLOBAL AI IN RARE DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Machine Learning
  • Deep Learning
  • Natural Language Processing
  • Computer Vision
  • Others

GLOBAL AI IN RARE DISEASE DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Genetic Disorders
  • Metabolic Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Others

GLOBAL AI IN RARE DISEASE DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals
  • Research Institutes
  • Diagnostic Centers
  • Others

GLOBAL AI IN RARE DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. AI in Rare Disease Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI in Rare Disease Diagnostics Market Snippet by Component
    • 2.1.2. AI in Rare Disease Diagnostics Market Snippet by Deployment Mode
    • 2.1.3. AI in Rare Disease Diagnostics Market Snippet by Technology
    • 2.1.4. AI in Rare Disease Diagnostics Market Snippet by Application
    • 2.1.5. AI in Rare Disease Diagnostics Market Snippet by End User
    • 2.1.6. AI in Rare Disease Diagnostics Market Snippet by Country
    • 2.1.7. AI in Rare Disease Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. AI in Rare Disease Diagnostics Key Market Trends

  • 3.1. AI in Rare Disease Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI in Rare Disease Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI in Rare Disease Diagnostics Market Opportunities
  • 3.4. AI in Rare Disease Diagnostics Market Future Trends

4. AI in Rare Disease Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI in Rare Disease Diagnostics Market : Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. AI in Rare Disease Diagnostics Market Landscape

  • 6.1. AI in Rare Disease Diagnostics Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI in Rare Disease Diagnostics Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
    • 7.1.2. Software
    • 7.1.3. Hardware
    • 7.1.4. Services

8. AI in Rare Disease Diagnostics Market - By Deployment Mode

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Deployment Mode, 2025 & 2033 (%)
    • 8.1.2. Cloud-Based
    • 8.1.3. On-Premises

9. AI in Rare Disease Diagnostics Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 9.1.2. Machine Learning
    • 9.1.3. Deep Learning
    • 9.1.4. Natural Language Processing
    • 9.1.5. Computer Vision
    • 9.1.6. Others

10. AI in Rare Disease Diagnostics Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Genetic Disorders
    • 10.1.3. Metabolic Disorders
    • 10.1.4. Neurological Disorders
    • 10.1.5. Oncology Disorders
    • 10.1.6. Others

11. AI in Rare Disease Diagnostics Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Research Institutes
    • 11.1.4. Diagnostic Centers
    • 11.1.5. Others

12. AI in Rare Disease Diagnostics Market - By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. AI in Rare Disease Diagnostics Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. AI in Rare Disease Diagnostics Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.18. Denmark
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Denmark Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Denmark Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.19. Rest of Europe
      • 12.3.19.1. Overview
      • 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.19.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.19.4. Rest of the Europe Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.3.19.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.19.6. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. AI in Rare Disease Diagnostics Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.17. Taiwan
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Taiwan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Taiwan Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.18. Vietnam
      • 12.4.18.1. Overview
      • 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.18.3. Vietnam Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.18.4. Vietnam Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.18.5. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.18.6. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.19. Rest of APAC
      • 12.4.19.1. Overview
      • 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.19.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.19.4. Rest of APAC Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.4.19.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.19.6. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. AI in Rare Disease Diagnostics Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. AI in Rare Disease Diagnostics Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.15. Iran
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Iran Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Iran Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.16. Qatar
      • 12.6.16.1. Overview
      • 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.16.3. Qatar Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.16.4. Qatar Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.6.16.5. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.16.6. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.17. Rest of MEA
      • 12.6.17.1. Overview
      • 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.17.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.17.4. Rest of MEA Market Size and Forecast, By Deployment Mode, 2020 - 2033 (US$ Million)
      • 12.6.17.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.17.6. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- AI in Rare Disease Diagnostics Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Bayer
    • 13.2.2. Deep Genomics
    • 13.2.3. Congenica
    • 13.2.4. Enlitic
    • 13.2.5. Face2Gene
    • 13.2.6. BioMind
    • 13.2.7. Fabric Genomics
    • 13.2.8. FDNA
    • 13.2.9. IBM Watson Health
    • 13.2.10. Invitae
    • 13.2.11. Freenome
    • 13.2.12. GeneDx
    • 13.2.13. Mendel.ai
    • 13.2.14. Nostos Genomics
    • 13.2.15. PathAI
    • 13.2.16. SOPHiA GENETICS
    • 13.2.17. Tempus Labs
    • 13.2.18. PhenoTips
    • 13.2.19. Raremark
    • 13.2.20. Others

14. 360 Degree AnalystView

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us